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When treating more complex target volumes, like pelvic nodes (Type 
2), we could not achieve better dose distributions with the SS method, 
namely in terms of OARs sparing and we were not able to take 
advantage of the reduced number of segments and MU, associated 
with the SS method. 
No significant differences were found in terms of IMRT QA.  
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Purpose/Objective: Objective of the present work is to evaluate the 
influence of increase in dose rate on dynamic IMRT plan quality and 
deliverability. 
Materials and Methods: Three previously treated patients of 
carcinoma prostate were chosen. Planning target volume (PTV) and 
organ at risk (OAR) i.e. bladder and rectum were contoured. Dynamic 
SIB-IMRT plans were created in Eclipse treatment planning system 
(TPS) for Varian CL2300C/D linear accelerator. Seven equi-spaced 
fields with 6MV photon beam at 300MU/min dose rate with 2.5cm/sec 
maximum allowable leaf velocity was used. The plan was then re-
optimized by keeping all the parameters constant, only dose rate was 
varied as follows: 400MU/min, 500MU/min and 600MU/min. 
Therefore, for each patient, four different plans were created. 
Prescription dose was 74Gy for PTV primary(PTV-P) and 54Gy for PTV 
Nodal (PTV-N) in 27 fractions and dose was prescribed at 95% isodose 
line. Plan quality was analyzed by means maximum and mean doses of 
PTV and OAR. Normal tissue integral dose (N.T.I.D.) (liter-Gray) of 
normal tissue volume (i.e., patient volume minus PTV-P and PTV-PA) 
was also calculated. Dose rate of 300MU/min was taken as reference. 
For accuracy of deliverability, treatment plans were verified with 
I’matriXX ion-chamber array and compared with TPS dose-plane by 
using gamma (γ) index of 3% dose difference and 3mm distance to 
agreement (DTA) criteria. Percentage of pixels passing gamma value 
up to 1(γ% ≤1) were noted. In addition, total monitor units (MUs) 
required to deliver a plan and machine beam ON time (min) were also 
noted. 
Results 
Results are summarized in Table-1 
 
Conclusions: There is no much dose difference was found for the PTV. 
However, slight difference was found for PTV-N maximum and mean 
doses. Similarly,increase in bladder mean dose, NTID and total 
number of MU increased with increase in dose rate. Beam ON time 
was lesser for higher dose rate. 2D gamma analysis showed almost 
comparable results for all dose rates.  
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Purpose/Objective: In 3D image-guided HDR gynaecological 
brachytherapy treatments, a consequence of the small size of the192Ir 
sources that are used for treatment combined with a steep dose 
gradient is that precise determination of source dwell positions 
becomes critical for accurate reconstruction of ring applicators. In 
comparison to CT and MRI which only allow for indirect reconstruction 
of applicators and consequent increase in associated reconstruction 
uncertainty, the use of film enables direct reconstruction of source 
dwell positions. This paper details a methodology and associated 
uncertainties relating to the reconstruction of ring applicators using 
gafchromic film. 
Materials and Methods: RTQA2 gafchromic films were attached to the 
surface of Nucletron interstitial ring applicators and irradiated at pre-
programmed dwell positions 1 cm apart in the configuration shown in 
figure 1. Four, three and one sets of Ø26 mm, Ø30 mm, and Ø34 mm 
ring applicators respectively were used for this study. The irradiated 
films were digitized using an Epson Expression 10000XL scanner. The 
coordinates of the source dwell positions were identified and the 
source path for the rings characterized by investigating correlations 
between the source path and movement of the source cable. 
Measurements were repeated over a period of nine months using three 
consecutive 192Ir sources and inter applicator and inter source dwell 
position differences investigated.  
 
  
Results: The source path was observed to deviate from the cable path 
by up to 30% leading to a cumulative deviation in expected source 
dwell position of at least 5 mm in all ring applicators. The inter 
applicator and inter source differences in source dwell positions were 
observed to be within the associated measurement uncertainties for 
the Ø30 mm and Ø34 mm ring applicators. Significant differences 
were observed between sets of the Ø26 mm ring applicators. The total 
expanded uncertainties associated with the determination of source 
positions in the applicators and presented in table 1, showed a 
maximum intra applicator average total expanded uncertainty (k=2) of 
1.14 ± 0.30 mm, 1.19 ± 0.14 mm and 1.04 ± 0.30 mm for the Ø26 mm, 
Ø30 mm and Ø34 mm ring applicator sets respectively. The inter 
applicator average total expanded unceratinty was also observed to 
be 1.07 ± 0.11 mm and 1.09 ±0.05 mm for the Ø26 mm and Ø30 mm 
ring applicators. 
 
PATIENT Patient 1 Patient 2 Patient 3  
DOSE 
RATE 
RATIO 
300 
300 
400 
300 
500 
300 
600 
300 
300 
300 
400 
300 
500 
300 
600 
300 
300 
300 
400 
300 
500 
300 
600 
300 
PTV-P 
MAX. 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.001 1.000 
PTV-P 
MEAN 1.000 0.999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.001 
PTV-N 
MAX. 1.000 1.000 1.000 1.001 1.000 1.001 1.002 1.002 1.000 0.999 0.999 1.000 
PTV-N 
MEAN 1.000 1.000 1.000 1.001 1.000 1.000 1.000 1.001 1.000 1.000 1.000 1.001 
BLADDER 
MAX 1.000 1.000 1.000 1.001 1.000 0.999 1.000 1.000 1.000 1.000 1.000 1.000 
BLADDER 
MEAN 1.000 1.000 1.002 1.003 1.000 1.001 1.002 1.003 1.000 1.001 1.003 1.005 
RECTUM 
MAX 1.000 1.000 1.000 1.001 1.000 0.999 1.000 1.000 1.000 1.000 1.002 1.002 
RECTUM 
MEAN 1.000 1.000 1.000 1.001 1.000 1.000 1.001 1.002 1.000 1.001 1.001 1.002 
N .T. 
I. D. 1.000 1.003 1.006 1.009 1.000 1.003 1.006 1.009 1.000 1.002 1.005 1.007 
PATIENT Patient 1 Patient 2 Patient 3  DOSE 
RATE 300 400 500 600 300 400 500 600 300 400 500 600 
TOTAL 
MU 
1565 
MU 
1931 
MU 
2024 
MU 
2112 
MU 
2254 
MU 
2337 
MU 
2426 
MU 
2513 
MU 
2322 
MU 
2389 
MU 
2468 
MU 
2552 
MU 
BEAM ON 
TIME  
6.78 
min. 
5.35 
min. 
4.43 
min. 
4.01 
min. 
7.80 
min. 
6.25 
min. 
5.15 
min. 
4.28 
min. 
7.83 
min. 
6.18 
min. 
5.10 
min. 
4.45 
min. 
γ INDEX 
(γ% ≤1) 
98.97 
% 
99.11
% 
98.95 
% 
99.02 
% 
99.78
% 
99.87 
% 
99.56 
% 
99.68
% 
99.48 
% 
99.39 
% 
99.44
% 
99.44 
% 
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Conclusions: The source path for ring applicators is dependent on the 
geometry of the ring. The geometry of the ring causes the source 
cable to travel along a characteristic path that is different compared 
to the path of the source and has the effect of introducing significant 
deviation of the source from its expected position in the lumen along 
its direction of motion. The observation of significant differences 
between sets of Ø26 mm ring applicators has shown that, in some 
cases, multiple sets of the same applicator size can not be 
characterized by a single source path. Consequently, care must be 
taken to ensure that the source path of each ring is measured first. 
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Purpose/Objective: Whilst CP is used in routine clinical practice for 
DQA purposes prior to HT treatment, practicalities could necessitate 
the use of OP as a backup measure. This study investigates the 
validation of OP octagonal QA tool (vol 0.125cc) in contrast to the 
circular CP (0.057cc). 
Materials and Methods: Treatment plans of 10 patients were selected 
and a homogenous high dose PTV area was selected for DQA. The 
images of Phantoms inserted with the ionisation chambers was 
imported from the CT scan to theTomotherapy Treatment Planning 
System (TPS); following which recalculation of the clinical plan was 
done with the above phantoms for verification purposes. Results of 
the DQA using the two processes were compared. 
Results: The standard deviation of the measured doses of A1SL 
Chamber with cheese Phantom with the TPS calculated dose was 1.24 
versus semiflex Chamber with Ocatavius Phantom was 0.979. For 
Fluence map comparison using Octavius phantom, significant 
adjustments were made to the beam profile measured by 729 2-d 
array; but after shifting the coordinates a match was achieved to the 
TPS calculated fluence. 
Conclusions: The Deviation of the Point Dose measurements of DQA 
inTomotherapy with A1SL chamber Cheese Phantom) and semiflex 
chamber (Ocatavius Phantom) was within the accepted 1.24 and 0.979 
were within tolerance limit (3%). Hence the point dose measurement 
of DQA plan in tomotherapy can be done with the semiflex ion 
chamber along with the octavius phantom. 2d array was also possible 
using a manual adjustment to the fluence coordinates using Octavius 
phantom. Octavius phantom could therefore be used for DQA of HT 
plans. 
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Purpose/Objective: Inverse planned intensity modulated radiotherapy 
(IMRT) for carcinomas of the head and neck requiring bilateral 
treatment can reduce toxicity through parotid sparing and is standard 
practice. However lateralised carcinomas of the head and neck are 
often treated using forward planned conformal radiotherapy due to 
inherent sparing of the opposite parotid. Furthermore the beam 
arrangement, increased number of monitor units and longer delivery 
times generally associated with IMRT may result in a greater dose to 
volume outside the PTV. This study compares the dose distributions 
from lateralised IMRT to forward planned, three dimensional 
conformal radiotherapy (3D-CRT), in patients with unilateral 
carcinomas in the head and neck region. 
Materials and Methods: IMRT and 3D-CRT plans were created for 
seven patients with lateralised disease where the clinical target 
volume included retropharyngeal nodal levels I-V. Beam arrangements 
for the IMRT plans were similar to that used for 3D-CRT with beams 
entering only from the ipsilateral side to avoid dose bath. Plans were 
created for an Elekta Synergy linac at 6MV using step-and-shoot IMRT 
and fixed angle VMAT techniques using Monaco (v3.20.01). 3D-CRT 
plans created using XiO (v4.70.01). Dose-volume histograms were 
generated for each plan to compare doses to PTV, OARs and normal 
tissue. Heterogeneity and Conformity Index for PTV were also 
evaluated. Monitor units were compared to estimate peripheral doses 
in the patient for each case. 
Results: Dose coverage for the 3D-CRT plans tends to be compromised 
in order to meet OAR constraints. The use of IMRT is seen to improve 
both PTV coverage and conformity whilst maintaining doses to organs 
at risk. Since beams were not entering through the contralateral side 
of the patient the usual dose bath from IMRT is avoided. In the cases 
where using IMRT resulted in an increase in volume of surrounding 
tissue receiving dose, it was the volume receiving 10% or less of the 
prescribed dose that was most effected and an average decrease in 
MU of 33% was observed for the IMRT plans. 
Conclusions: The use of lateralised delivery of IMRT for unilateral 
head and neck cancers shows improved coverage of the PTV without 
compromising dose to organs at risk or resulting in an unacceptable 
dose bath. 
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Purpose/Objective: In September 2012, the Elekta Agility MLC was 
clinically introduced in our clinic. The Agility has 160 leaves of 5mm 
width over the full 40x40 cm field, with a very low transmission of < 
0.5%. Leaves can interdigitate and move at high speed. Initially, we 
only had a single Agility linac and five MLCi2 linacs (with 10 mm 
leaves), so we aimed at maintaining exchangeability of patients 
between machines, without having to replan or reoptimize. In this 
presentation, we would like to highlight some pitfalls and practical 
issues encountered before and during clinical implementation. 
Materials and Methods: The Agility was modelled in the Pinnacle3 
Treatment planning system (version 9.0). Even though the Agility has 
no backup jaws, in Pinnacle the jaws are present (even though they 
do not influence the dose computation). This can cause confusion, 
especially since the non-existent jaws can block the rendering of the 
actual leaf settings of the Agility. For each treatment that needed 
exchangeability,we first created a plan for the MCLi2. Using a 
Pinnacle script in combination with UNIX level programming, the 
beams of the plan were duplicated and converted to the Agility, 
creating a sum plan of both ‘plans’. In this step, single MLCi2 leaves 
were replaced by two Agility leaves. Furthermore, since the Agility 
does not have backup jaws, the position of the diaphragm jaws were 
automatically adjusted to shield the flagpoles that were no longer 
blocked by the backup jaws of the MLCi2.  
Results: After the conversion, we observed dose differences between 
original MLCi2 plan and the automatically converted Agility plan of up 
to 3 per cent for complex IMRT plans, which made adjustment of the 
number of monitor units for the Agility plans necessary. For some 3D-
CRT plans, we encountered problems in the conversion when backup 
jaws for the MLCi2 were manually positioned beyond the leaves.  
Conclusions: In clinical practice we found that it was difficult to find 
an algorithm to automatically convert from MLCi2 to Agility with 100% 
accuracy.Therefore, automatic conversion should be seen as an ‘aid’. 
One must take extreme care and dose distributions of MLCi2 and 
Agility plans must be compared vigorously, both using the DVH and the 
3D dose distribution. As soon as multiple Agility linacs were available 
in our institute, we stopped the conversion and prepared just one plan 
for each treatment, depending on the linac on which the treatment 
was performed. 
   
 
 
 
 
 
